On October 19, 2021, Cisema will take part in a webinar session organized by the United States Commercial Service with other speakers from IQVIA and U.S. PTO Shanghai.
This webinar will focus on market opportunities, regulatory requirements, and IP protection for China’s medical device market. In addition to analysis of the general NMPA regulatory requirements and registration pathways, the presentation will discuss recent ongoing NMPA policies/practices such as UDI implementation, clinical trial exemption listing, and the reclassification situation/tendency (e.g. Class III reclassified as Class II, or Class II as Class I).
Webinar Date: Tuesday, October 19, 2021 (08:00am – 09:10am, China time)
Speakers: IQVIA (Eric Shao, General Manager), Cisema (Hamish, COO), and U.S. PTO Shanghai (Juli Schwartz, IP Attaché)
Language: English
Tentative Agenda:
- Introduction
- Opening Remarks by US Commercial Services
- China Medical Device Market Overview by IQVIA
- NMPA Regulatory Requirements and Registration Pathway by Cisema
- IP Protection in China by U.S. PTO Shanghai
- CS Services and Trade Show Opportunities by CS China
*A 10-min Q&A session will be available after the 60-min webinar.
Registration link to be announced on a further date.
Contact Cisema if you would like to learn more.
